Heterozygous and Homozygous Variants in


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
11 Apr 2022
Historique:
received: 15 03 2022
revised: 05 04 2022
accepted: 09 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

In the last few years, the SORL1 gene has been strongly implicated in the development of Alzheimer’s disease (AD). We performed whole-exome sequencing on 37 patients with early-onset dementia or family history suggestive of autosomal dominant dementia. Data analysis was based on a custom panel that included 46 genes related to AD and dementia. SORL1 variants were present in a high proportion of patients with candidate variants (15%, 3/20). We expand the clinical manifestations associated with the SORL1 gene by reporting detailed clinical and neuroimaging findings of six unrelated patients with AD and SORL1 mutations. We also present for the first time a patient with the homozygous truncating variant c.364C>T (p.R122*) in SORL1, who also had severe cerebral amyloid angiopathy. Furthermore, we report neuropathological findings and immunochemistry assays from one patient with the splicing variant c.4519+5G>A in the SORL1 gene, in which AD was confirmed by neuropathological examination. Our results highlight the heterogeneity of clinical presentation and familial dementia background of SORL1-associated AD and suggest that SORL1 might be contributing to AD development as a risk factor gene rather than as a major autosomal dominant gene.

Identifiants

pubmed: 35457051
pii: ijms23084230
doi: 10.3390/ijms23084230
pmc: PMC9024679
pii:
doi:

Substances chimiques

LDL-Receptor Related Proteins 0
Membrane Transport Proteins 0
SORL1 protein, human 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI17/01067
Organisme : Agency for Administration of University and Research
ID : 2017SGR1134
Organisme : Instituto de Salud Carlos III
ID : CM 18/0095
Organisme : Instituto de Salud Carlos III
ID : JR 18/00046

Références

Ann Clin Transl Neurol. 2018 May 24;5(7):832-842
pubmed: 30009200
BMC Neurol. 2019 May 15;19(1):97
pubmed: 31092209
Mol Psychiatry. 2016 Jun;21(6):831-6
pubmed: 26303663
Acta Neuropathol. 2019 Aug;138(2):173-186
pubmed: 30911827
J Mol Diagn. 2018 Jan;20(1):4-27
pubmed: 29154853
Oncotarget. 2017 Dec 15;9(19):15132-15143
pubmed: 29599933
J Alzheimers Dis. 2018;61(4):1275-1281
pubmed: 29376855
J Alzheimers Dis. 2017;56(1):63-74
pubmed: 27911290
Neurobiol Dis. 2020 Aug;142:104946
pubmed: 32439597
J Alzheimers Dis Rep. 2020 May 02;4(1):123-140
pubmed: 32587946
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Sci Rep. 2019 Jun 10;9(1):8368
pubmed: 31182772
Eur J Hum Genet. 2017 Aug;25(8):973-981
pubmed: 28537274
Ann Neurol. 1995 Aug;38(2):254-9
pubmed: 7654074
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
J Alzheimers Dis. 2018;62(2):821-831
pubmed: 29480197
Neurology. 2010 Apr 27;74(17):1346-50
pubmed: 20421578
J Alzheimers Dis. 2018;62(3):913-932
pubmed: 29562532
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Neurol Genet. 2016 Oct 26;2(6):e116
pubmed: 27822510
J Alzheimers Dis. 2021;79(3):1105-1119
pubmed: 33386808
Cold Spring Harb Mol Case Stud. 2019 Dec 13;5(6):
pubmed: 31836585
Hum Hered. 2016;81(3):129-141
pubmed: 28002825
J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):41-4
pubmed: 20667857
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Neurology. 2007 Apr 24;68(17):1411-6
pubmed: 17452586
Alzheimers Dement. 2016 Jun;12(6):733-48
pubmed: 27016693
Mol Psychiatry. 2011 Sep;16(9):903-7
pubmed: 21556001
Acta Neuropathol Commun. 2017 Jun 9;5(1):43
pubmed: 28595629
Alzheimers Dement. 2022 Jan;18(1):10-28
pubmed: 34057813
Neurology. 2009 Nov 3;73(18):1451-6
pubmed: 19884572
Mol Brain. 2020 Oct 19;13(1):142
pubmed: 33076949
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Neurologist. 2012 Nov;18(6):356-63
pubmed: 23114667
J Alzheimers Dis. 2017;58(3):631-659
pubmed: 28505974
J Alzheimers Dis. 2016 Apr 4;52(3):781-99
pubmed: 27060961
Cell Rep. 2020 Jun 2;31(9):107719
pubmed: 32492427
Neurobiol Aging. 2020 Sep;93:e1-e9
pubmed: 32317127
Acta Neuropathol. 2012 Jan;123(1):1-11
pubmed: 22101365
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Nucleic Acids Res. 2016 Jun 20;44(11):e108
pubmed: 27060149
Acta Neuropathol. 2016 Aug;132(2):213-224
pubmed: 27026413
Ann Neurol. 2015 Feb;77(2):215-27
pubmed: 25382023

Auteurs

Maria Isabel Alvarez-Mora (MI)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Biochemistry and Molecular Genetic Service, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.

Victor Antonio Blanco-Palmero (VA)

Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Juan Francisco Quesada-Espinosa (JF)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Ana Rosa Arteche-Lopez (AR)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Sara Llamas-Velasco (S)

Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Carmen Palma Milla (C)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Jose Miguel Lezana Rosales (JM)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Irene Gomez-Manjon (I)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Aurelio Hernandez-Lain (A)

Neuropathology Unit, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Justino Jimenez Almonacid (J)

Neuropathology Unit, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Belén Gil-Fournier (B)

Genetic Service, Hospital Universitario de Getafe, 28905 Madrid, Spain.

Soraya Ramiro-León (S)

Genetic Service, Hospital Universitario de Getafe, 28905 Madrid, Spain.

Marta González-Sánchez (M)

Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Alejandro Octavio Herrero-San Martín (AO)

Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

David Andrés Pérez-Martínez (DA)

Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Estrella Gómez-Tortosa (E)

Neurology Department, Fundación Jiménez Díaz, 28040 Madrid, Spain.

Eva Carro (E)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Fernando Bartolomé (F)

Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain.
Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Maria Jose Gomez-Rodriguez (MJ)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Network Center for Biomedical Research in Cancer (CIBERONC), 28029 Madrid, Spain.

María Teresa Sanchez-Calvin (MT)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Alberto Villarejo-Galende (A)

Neurology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Group of Neurodegenerative Diseases, Instituto de Investigación Hospital 12 de Octubre (i+12), 28041 Madrid, Spain.

Marta Moreno-Garcia (M)

Genetic Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
UdisGen-Unidad de Dismorfología y Genética, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH